# Federal Register #2026-22556

DEA Controlled-Substance Registration Applications for Remifentanil and Pentobarbital

**Posted:** November 05, 2026
**Respond By:** January 04, 2027
**Identifier:** 2026-22556

This notice excerpt concerns controlled-substance registration applications, not a government purchase or award.
- Government agency: U.S. Department of Justice, Drug Enforcement Administration (DEA); no specific office is identified.
- **Named manufacturers:** Navinta LLC applied to bulk manufacture remifentanil for distribution to customers. Diamond Animal Health, Inc. applied to import pentobarbital to support manufacture of Euthasol, a Schedule III(N) finished dosage form.
- Substances and identifiers:
  - Remifentanil — drug code 9739, Schedule II; quantity not specified.
  - Pentobarbital — drug code 2270, Schedule II; quantity not specified.
- The applications concern controlled-substance registrations; no products or services are being purchased, and no procurement quantities, contract value, or performance period are provided.

### Description

Navinta LLC applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of the controlled substance remifentanil (drug code 9739, Schedule II). The notice states the company plans to bulk manufacture the substance for distribution to its customers, and no other activity for this drug code is authorized under the registration. Eligible parties may submit comments or objections, or request a hearing, on or before January 4, 2027.

[View original listing](https://www.federalregister.gov/documents/2026/11/05/2026-22556/bulk-manufacturer-of-controlled-substances-application-navinta-llc)